Regenerative peptides are widely researched for soft-tissue repair, tendon and ligament recovery, joint health, and reducing downtime from training or injury.
16 peptides commonly researched for this goal. Tap any card for the full guide.
The best-known 'healing peptide' in the research community, prized for tendon and gut repair claims. Backed almost entirely by animal data, not human trials.
Read the guideTB-500 is the synthetic cousin of full-length Thymosin Beta-4, used off-label for full-body recovery rather than a single injury site.
Read the guideThe full-length parent molecule behind TB-500, with more actual human trial exposure, mostly in eye and cardiac research.
Read the guideA copper-carrying tripeptide with real cosmetic-industry backing. One of the few peptides on this list with legitimate topical clinical data.
Read the guideAn EPO-derived peptide with actual Phase 2 human trial data behind its anti-inflammatory, nerve-pain claims.
Read the guideA small anti-inflammatory fragment of alpha-MSH, studied mostly in gut-inflammation animal models.
Read the guideA naturally occurring antimicrobial peptide the body already makes. Studied clinically as a chronic-wound treatment.
Read the guideNot a true peptide, but common in joint-health peptide stacks. It carries a real long-term retinal safety signal worth surfacing prominently.
Read the guideA GHRH analog that comes in a long-acting (DAC) and short-acting (no-DAC/Mod GRF) form. The choice materially changes the risk/use profile.
Read the guideA mitochondrial-encoded 'exercise mimetic' peptide with strong lab-bench interest but very little human data yet.
Read the guideA Russian-approved nootropic/stroke-recovery peptide with decades of clinical use abroad, but no Western regulatory approval.
Read the guideA complex, multi-peptide brain-derived preparation with real international clinical use for stroke and dementia, though it's not a clean single-molecule peptide.
Read the guideOne of the few 'longevity peptides' with actual elderly-cohort human trial data behind it. From a specific, not-widely-replicated Russian research program.
Read the guideA mitochondria-targeted peptide with real clinical-trial pedigree in rare mitochondrial diseases and heart failure.
Read the guideA true FDA-approved bone-building peptide drug for severe osteoporosis. Worth including as a legitimate clinical anchor in the joint/bone category.
Read the guideA newer FDA-approved cousin of teriparatide for osteoporosis, with a similar mechanism and safety profile.
Read the guideRecovery peptides are the compounds people reach for when a tendon won't settle down, a gut won't calm down, or training keeps outrunning the body's ability to repair. This page compares 16 of them. The research community leans hardest on a handful: BPC-157 for tendon and gut repair, TB-500 and full-length Thymosin Beta-4 for full-body soft-tissue recovery, GHK-Cu for skin and wound work, and ARA-290 for inflammation and nerve pain. Each one gets studied for a slightly different job.
Be clear-eyed about the evidence, because it varies a lot. BPC-157 and TB-500 are the two most talked-about healing peptides here, and both are backed almost entirely by animal data, not human trials. Others sit at the opposite end. ARA-290 has actual Phase 2 human data behind its anti-inflammatory claims, GHK-Cu has legitimate topical clinical data, and Teriparatide and Abaloparatide are FDA-approved bone-building drugs. Where a compound has been tested in people, we say so. Where it hasn't, we say that too. This is educational, not medical advice, and none of it is a protocol.
| Peptide | Category | Studied for | Evidence |
|---|---|---|---|
| BPC-157Body Protection Compound 157 | Healing & Recovery | Recovery & Healing | Extensive research |
| TB-500Thymosin Beta-4 fragment | Healing & Recovery | Recovery & Healing, Muscle Growth | Extensive research |
| Thymosin Beta-4 (full length)Tβ4 | Healing & Recovery | Recovery & Healing | Moderate research |
| GHK-CuCopper peptide | Healing & Recovery | Recovery & Healing, Skin & Hair | Extensive research |
| ARA-290Cibinetide | Healing & Recovery | Recovery & Healing, Cognitive Function | Moderate research |
| KPVLys-Pro-Val | Healing & Recovery | Recovery & Healing, Cognitive Function | Limited research |
| LL-37Cathelicidin | Healing & Recovery | Recovery & Healing, Immune Support | Moderate research |
| Pentosan PolysulfateJoint | Healing & Recovery | Recovery & Healing | Moderate research |
| CJC-1295CJC-1295 with DAC | Growth Hormone Secretagogues | Muscle Growth, Longevity | Extensive research |
| MOTS-cMitochondrial-derived peptide | Metabolic & Longevity | Longevity, Energy & Metabolism | Moderate research |
| SemaxNootropic peptide | Cognitive & Neuroprotective | Cognitive Function, Recovery & Healing | Moderate research |
| CerebrolysinNeuropeptide preparation | Cognitive & Neuroprotective | Cognitive Function, Recovery & Healing | Moderate research |
| EpithalonEpitalon | Longevity & Cellular Health | Longevity, Sleep | Moderate research |
| SS-31 (Elamipretide)Mitochondrial peptide | Longevity & Cellular Health | Longevity, Energy & Metabolism | Moderate research |
| TeriparatideForteo | Bone & Joint | Recovery & Healing | Extensive research |
| AbaloparatideTymlos | Bone & Joint | Recovery & Healing | Moderate research |
Most of these compounds act on the repair process rather than numbing a symptom. BPC-157, a stable fragment studied for tendon, ligament, and gut lining, is researched for its effect on new blood vessel growth and connective-tissue repair in animal models. TB-500 and Thymosin Beta-4 are thought to influence cell migration and tissue regeneration across the whole body rather than a single injury site. KPV is a small anti-inflammatory fragment of alpha-MSH, looked at mostly in gut-inflammation models. GHK-Cu carries copper and shows up in real cosmetic and wound research. These are proposed mechanisms from lab work, not settled human outcomes.
There's no single best pick, because the goals differ. For soft tissue and tendons, BPC-157 is the most-discussed name, and TB-500 gets used off-label when the aim is full-body recovery instead of one spot. If you care about the strongest human evidence, the picture shifts. ARA-290 has Phase 2 trial data, GHK-Cu has topical clinical backing, and for bone, Teriparatide and Abaloparatide are FDA-approved for osteoporosis. LL-37 has been studied clinically for chronic wounds. Pentosan Polysulfate turns up in joint stacks but isn't a true peptide and carries a long-term retinal safety signal worth knowing. Match the compound to the tissue and to how much evidence you want behind it.
The honest summary: excitement runs ahead of human data for most of the popular names. BPC-157 and TB-500 have generated promising animal results and plenty of anecdote, but human trials are thin to nonexistent, and that gap matters for both safety and effect size. A few peptides here are genuine clinical anchors. ARA-290 reached Phase 2, GHK-Cu has real topical data, and Teriparatide and Abaloparatide went through full FDA approval for bone loss. Others, like KPV, sit at the limited end with mostly preclinical work. Strong lab results are a reason to pay attention, not proof something works in people.
It depends on the tissue and how much evidence you want. BPC-157 is the most-discussed for tendon and gut repair, and TB-500 for full-body recovery, but both rest mainly on animal data. If human evidence is your priority, ARA-290 has Phase 2 trials and GHK-Cu has topical clinical data. There's no universal best answer.
BPC-157 shows consistent tendon, ligament, and gut-repair results in animal studies, which is why the research community talks about it so much. The honest caveat: it's backed almost entirely by animal data, not human trials. So the mechanism is interesting and the anecdotes are common, but rigorous human evidence for its effects and long-term safety isn't there yet.
Safety varies widely across these 16 compounds and isn't well established for most. Popular names like BPC-157 and TB-500 lack human safety trials. Some carry specific flags: Pentosan Polysulfate has a long-term retinal safety signal. Others, like Teriparatide, went through full FDA review. This is educational, not medical advice. Talk to a qualified clinician before considering anything here.
BPC-157 is the peptide most associated with tendon and ligament repair in the research community, based largely on animal studies. TB-500 and full-length Thymosin Beta-4 are also studied for soft-tissue recovery. None of these has strong human trial data for tendons specifically, so the interest comes from lab work and user reports rather than proven clinical outcomes.
Yes, a few. ARA-290 reached Phase 2 human trials for its anti-inflammatory and nerve-pain claims. GHK-Cu has legitimate topical clinical data. Teriparatide and Abaloparatide are FDA-approved bone-building drugs for osteoporosis, and LL-37 has been studied clinically for chronic wounds. The best-known names, BPC-157 and TB-500, are the ones that mostly lack it.
They're used for different recovery goals. BPC-157 is typically studied for a specific injury site, especially tendon and gut repair. TB-500, a synthetic fragment of Thymosin Beta-4, is used off-label for full-body recovery rather than one localized spot. Both are supported mainly by animal data. Full-length Thymosin Beta-4 has more actual human trial exposure, mostly in eye and cardiac research.
Educational information only. This is not medical advice. Peptide AI is an informational and tracking platform. Everything on this page is for general education. It is not a substitute for professional medical advice and is not a recommendation to use any compound. Many peptides listed here are research compounds the FDA has not approved for human use. Talk to a qualified, licensed healthcare provider before you start, change, or stop any protocol.
Peptide AI joins your doses, labs, and wearables so you can see which compounds actually move your numbers.